A Decade of Progress in Advanced Breast Cancer: Unveiling the Inequalities and the Path Forward
The battle against advanced breast cancer (ABC) has seen remarkable advancements in the past decade, with a new study shedding light on the dramatic improvements in survival rates. However, the report also highlights a stark reality: while life-extending treatments are saving lives, they are not accessible to everyone. The Advanced Breast Cancer Global Decade Report 2015–2025, a collaborative effort by the ABC Global Alliance and VML Health, reveals a complex landscape of progress and persistent challenges.
Survival Rates: Rising, but Not for All
The global five-year median survival for women with ABC has climbed to an impressive 33%, up from 26% a decade ago. This progress is fueled by improved therapies and international consensus guidelines that have been integrated into clinical practice. Yet, the story is not uniform across all patient groups. Women with triple-negative breast cancer have seen little change, with a median overall survival of just 13 months. On the other hand, HER2-positive disease shows promise, with real-world median survival exceeding 50 months in some regions. These disparities emphasize the need for tailored treatment approaches.
Treatment Inequality: A Global Disparity
The report exposes treatment inequality, with trastuzumab, a standard-of-care drug for HER2-positive ABC, accessible in only about half of low-middle-income countries, compared to nearly all high-income nations. This disparity highlights the urgent need to address financial and logistical barriers to treatment in underserved regions.
Data Gaps and Clinical Trial Participation
Furthermore, the study reveals significant gaps in data collection. Less than 20% of cancer registries worldwide consistently record the stage of cancer at diagnosis, impacting the quality of care and treatment optimization. Alarmingly, nearly four in five individuals with ABC have never participated in a clinical trial, underscoring the importance of diverse representation in research.
Emotional Toll and Support Needs
The emotional and psychological impact of ABC is profound. The survey, a first-of-its-kind, reveals that 79% of individuals with ABC experience a negative impact on their emotional and psychological well-being. Moreover, 73% report impaired ability to work or study, with one in five losing their job. This highlights the need for comprehensive support systems and a compassionate approach to care.
A Call for Action: The ABC Global Charter
The ABC Global Alliance's ABC Global Charter 2025–2035 outlines ten measurable goals, aiming to double median survival, improve data collection, expand person-centered support, and protect workplace rights. With breast cancer affecting 2.3 million people and claiming 666,000 lives annually, the urgency for action is undeniable. The focus is on driving innovation and equity in ABC care worldwide, ensuring that progress translates into tangible improvements for patients.
Conclusion: A Journey Towards Equity
In conclusion, the past decade has witnessed significant progress in ABC care, but the journey towards equity is far from over. The report serves as a call to action for governments, healthcare systems, and the industry to collaborate and address the disparities in treatment access, data collection, and support. By embracing a comprehensive approach, we can ensure that the progress made in ABC research translates into improved outcomes for patients worldwide.
